Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for chronic migraine prophylaxis
CTR20131192Phase 3Active
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in chronic migraine, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Aug 2014; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine
Beyond the preview
Go deeper on CTR20131192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131192.